PTK2 and acute myeloid leukemia: To investigate whether a higher expression of FAK was associated with a more primitive phenotype in AML, we compared previously published CD34 and FAK (PTK2) mRNA levels in AML cell lines and two AML patient cohorts [32,36,37].